Protection effect of salvianolate in type 2 diabetes rats

卫银芝,赵芳,熊世熙,干学东,龚斐,曹建雷,汪瀚,周斌
DOI: https://doi.org/10.3760/cma.j.issn.1673-4777.2013.11.026
2013-01-01
Abstract:Objective To explore the protection effect of salvianolate in type 2 diabetes rats.Methods Of 30 healthy male Wistar rats,20 were selected and fed high-fat and high-sucrose diet for 6 weeks.They were injected intraperitoneally streptozotocin (STZ,30 mg/kg).After 3 days,the rats with plasma glucose ≥ 17.8 mmol/L were as the rat model of diabetes(n =17) and randomly divided into the diabetes group(n =9) and salvianolate (15 mg/kg)treatment group (n =8).Other 10 heathy male wistar rats were included into the control group (group N,n =10).S group were treated with salvianolate by intraperitoneal injection for 8weeks.N and D groups rats were given saline.Eight weeks later,heart function was detected by Doppler echocardiography ; the pathological changes were observed under transmission electron microscope and light microscopy; the levels of Bcl-2 and Caspase-3 gene expressions were examined by fluorescence quantitative polymerase chain reaction.Results Compared with control group,cardiac myocyte apoptosis was significantly increased (14.57 ± 0.56) vs (0.87 ± 0.13) (P < 0.05) ; Bcl-2 expression was decreased(0.57 ± 0.05) vs (1.06 ± 0.09) (P < 0.05) ; Caspase-3 expression was significantly increased (1.94 ± 0.15) vs (1.02 ± 0.08) (P < 0.05).Compared with diabetes group,after given salvianolate treatment,apoptotic myocardial cells decreased[(6.16 ±0.64) vs (14.57 ±0.56)] (P <0.05) ;the level of myocardial Bcl-2 gene expression increased [(0.84 ± 0.09) vs (0.57 ± 0.05)] (P < 0.05) ; while Caspase-3 decreased [(1.37 ± 0.13) vs (1.94 ± 0.15)] (P < 0.05).Conclusion Salvianolate treatment can delay the development of type 2 diabetic cardiomyopathy and protect the heart.
What problem does this paper attempt to address?